Literature DB >> 12116271

Additional patient with del(12)(q21.2q22): further evidence for a candidate region for cardio-facio-cutaneous syndrome?

Katherine A Rauen1, Donna G Albertson, Daniel Pinkel, Philip D Cotter.   

Abstract

Cardio-facio-cutaneous (CFC) syndrome is characterized by a distinct facial appearance, cardiac defects, ectodermal anomalies and developmental delay. Recently, we reported a 19-month-old girl with phenotypic manifestations consistent with the CFC syndrome who had an interstitial deletion of the long arm of chromosome 12, del(12)(q21.2q22), implicating a possible locus for CFC syndrome. Here, we report an additional patient with a cytogenetically identical interstitial deletion: 47,XYY,del(12)(q21.2q22). To further characterize this deletion we used microarray-based comparative genomic hybridization (array CGH). Array CGH confirmed both the deletion and the second Y chromosome. The deletion on chromosome 12q spanned at least 14 Mb as indicated by the positions on the genome sequence of the 4 BAC clones included in the deletion. While the proband did not have the classic features of CFC, he had some dysmorphic craniofacial characteristics, ectodermal anomalies and moderate developmental delay which were suggestive of CFC syndrome; however, this patient did not have classical CFC. The phenotypic differences between the two del(12)(q21.2q22) patients may be due to variability in the expression of the syndrome, or this deletion may present as a syndrome with overlapping features. Alternatively, the phenotypic differences may result from discordance at the molecular level, which may yield a critical minimal region of deletion for CFC. The region 12q21.2 --> q22 remains a possible candidate region for CFC syndrome. Additional characterization of these and other CFC patients may confirm and further refine this candidate region. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12116271     DOI: 10.1002/ajmg.10478

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

Review 1.  From microscopes to microarrays: dissecting recurrent chromosomal rearrangements.

Authors:  Beverly S Emanuel; Sulagna C Saitta
Journal:  Nat Rev Genet       Date:  2007-11       Impact factor: 53.242

Review 2.  Clinical application of array-based comparative genomic hybridization for the identification of prognostically important genetic alterations in chronic lymphocytic leukemia.

Authors:  Russell A Higgins; Shelly R Gunn; Ryan S Robetorye
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 3.  Chromosome analysis: what and when to request.

Authors:  F H Sharkey; E Maher; D R FitzPatrick
Journal:  Arch Dis Child       Date:  2005-12       Impact factor: 3.791

4.  Supernumerary marker chromosomes derived from chromosome 6: cytogenetic, molecular cytogenetic, and array CGH characterization.

Authors:  Bing Huang; Phyllis Pearle; Katherine A Rauen; Philip D Cotter
Journal:  Am J Med Genet A       Date:  2012-05-25       Impact factor: 2.802

5.  Ring chromosome 15: characterization by array CGH.

Authors:  Ian A Glass; Katherine A Rauen; Emily Chen; Jillian Parkes; Donna G Alberston; Daniel Pinkel; Philip D Cotter
Journal:  Hum Genet       Date:  2005-11-03       Impact factor: 4.132

Review 6.  12q21 Interstitial Deletions: Seven New Syndromic Cases Detected by Array-CGH and Review of the Literature.

Authors:  Maria Paola Recalcati; Ilaria Catusi; Maria Garzo; Serena Redaelli; Marta Massimello; Silvia Beatrice Maitz; Mattia Gentile; Emanuela Ponzi; Paola Orsini; Anna Zilio; Annamaria Montaldi; Annapaola Calò; Anna Paola Capra; Silvana Briuglia; Maria Angela La Rosa; Lucia Grillo; Corrado Romano; Sebastiano Bianca; Michela Malacarne; Martina Busè; Maria Piccione; Lidia Larizza
Journal:  Genes (Basel)       Date:  2022-04-27       Impact factor: 4.141

Review 7.  Comparative genomic hybridization arrays in clinical pathology: progress and challenges.

Authors:  Shelly R Gunn; Ryan S Robetorye; Mansoor S Mohammed
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  LIN7A depletion disrupts cerebral cortex development, contributing to intellectual disability in 12q21-deletion syndrome.

Authors:  Ayumi Matsumoto; Makoto Mizuno; Nanako Hamada; Yasuyuki Nozaki; Eriko F Jimbo; Mariko Y Momoi; Koh-ichi Nagata; Takanori Yamagata
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

9.  A New 12q21 Deletion Syndrome: A Case Report and Literature Review.

Authors:  Alessandra Di Nora; Greta De Costa; Alessia Di Mari; Marco Montemagno; Vito Pavone; Piero Pavone
Journal:  Glob Med Genet       Date:  2022-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.